vs

Side-by-side financial comparison of Brilliant Earth Group, Inc. (BRLT) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

Brilliant Earth Group, Inc. is the larger business by last-quarter revenue ($124.4M vs $121.8M, roughly 1.0× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -2.3%, a 6.5% gap on every dollar of revenue. On growth, Brilliant Earth Group, Inc. posted the faster year-over-year revenue change (4.1% vs -1.4%). Brilliant Earth Group, Inc. produced more free cash flow last quarter ($5.7M vs $517.0K). Over the past eight quarters, Brilliant Earth Group, Inc.'s revenue compounded faster (13.1% CAGR vs -3.4%).

Brilliant Earth is an American company that sells jewelry featuring diamonds and other gemstones that are asserted to be ethically sourced. The company was established in August 2005 by Beth Gerstein and Eric Grossberg, and is headquartered in San Francisco, California. According to Businessweek, the company has been influential in creating a market for ethically sourced jewelry. Some provenance claims were disputed as per a 2017 The Next Web article.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

BRLT vs CLB — Head-to-Head

Bigger by revenue
BRLT
BRLT
1.0× larger
BRLT
$124.4M
$121.8M
CLB
Growing faster (revenue YoY)
BRLT
BRLT
+5.5% gap
BRLT
4.1%
-1.4%
CLB
Higher net margin
CLB
CLB
6.5% more per $
CLB
4.2%
-2.3%
BRLT
More free cash flow
BRLT
BRLT
$5.2M more FCF
BRLT
$5.7M
$517.0K
CLB
Faster 2-yr revenue CAGR
BRLT
BRLT
Annualised
BRLT
13.1%
-3.4%
CLB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BRLT
BRLT
CLB
CLB
Revenue
$124.4M
$121.8M
Net Profit
$-2.9M
$5.1M
Gross Margin
55.9%
Operating Margin
-0.0%
1.5%
Net Margin
-2.3%
4.2%
Revenue YoY
4.1%
-1.4%
Net Profit YoY
-908.9%
EPS (diluted)
$-0.20
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRLT
BRLT
CLB
CLB
Q1 26
$121.8M
Q4 25
$124.4M
$138.3M
Q3 25
$110.3M
$134.5M
Q2 25
$108.9M
$130.2M
Q1 25
$93.9M
$123.6M
Q4 24
$119.5M
$129.2M
Q3 24
$99.9M
$134.4M
Q2 24
$105.4M
$130.6M
Net Profit
BRLT
BRLT
CLB
CLB
Q1 26
$5.1M
Q4 25
$-2.9M
$4.9M
Q3 25
$-107.0K
$14.2M
Q2 25
$-166.0K
$10.6M
Q1 25
$-466.0K
$-154.0K
Q4 24
$358.0K
$7.4M
Q3 24
$-141.0K
$11.7M
Q2 24
$185.0K
$9.0M
Gross Margin
BRLT
BRLT
CLB
CLB
Q1 26
Q4 25
55.9%
20.8%
Q3 25
57.6%
22.0%
Q2 25
58.3%
20.3%
Q1 25
58.6%
19.5%
Q4 24
59.6%
17.8%
Q3 24
60.8%
20.5%
Q2 24
60.8%
21.2%
Operating Margin
BRLT
BRLT
CLB
CLB
Q1 26
1.5%
Q4 25
-0.0%
11.5%
Q3 25
-0.6%
15.6%
Q2 25
-1.1%
11.7%
Q1 25
-3.8%
3.6%
Q4 24
2.0%
11.0%
Q3 24
-1.1%
14.7%
Q2 24
1.1%
12.3%
Net Margin
BRLT
BRLT
CLB
CLB
Q1 26
4.2%
Q4 25
-2.3%
3.6%
Q3 25
-0.1%
10.6%
Q2 25
-0.2%
8.2%
Q1 25
-0.5%
-0.1%
Q4 24
0.3%
5.7%
Q3 24
-0.1%
8.7%
Q2 24
0.2%
6.9%
EPS (diluted)
BRLT
BRLT
CLB
CLB
Q1 26
$0.11
Q4 25
$-0.20
$0.11
Q3 25
$-0.01
$0.30
Q2 25
$-0.01
$0.22
Q1 25
$-0.03
$0.00
Q4 24
$0.02
$0.15
Q3 24
$-0.01
$0.25
Q2 24
$0.01
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRLT
BRLT
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$79.1M
$22.8M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$12.3M
$275.1M
Total Assets
$200.9M
$587.7M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRLT
BRLT
CLB
CLB
Q1 26
$22.8M
Q4 25
$79.1M
$22.7M
Q3 25
$73.4M
$25.6M
Q2 25
$133.6M
$31.2M
Q1 25
$147.3M
$22.1M
Q4 24
$161.9M
$19.2M
Q3 24
$152.7M
$21.5M
Q2 24
$152.2M
$17.7M
Total Debt
BRLT
BRLT
CLB
CLB
Q1 26
Q4 25
$0
$110.3M
Q3 25
$0
$114.1M
Q2 25
$34.5M
$124.6M
Q1 25
$54.5M
$124.4M
Q4 24
$55.7M
$126.1M
Q3 24
$58.1M
$139.9M
Q2 24
$58.0M
$147.6M
Stockholders' Equity
BRLT
BRLT
CLB
CLB
Q1 26
$275.1M
Q4 25
$12.3M
$266.0M
Q3 25
$12.0M
$271.3M
Q2 25
$15.3M
$261.3M
Q1 25
$14.9M
$253.4M
Q4 24
$15.3M
$246.6M
Q3 24
$14.5M
$250.7M
Q2 24
$14.1M
$240.3M
Total Assets
BRLT
BRLT
CLB
CLB
Q1 26
$587.7M
Q4 25
$200.9M
$584.0M
Q3 25
$203.0M
$591.4M
Q2 25
$260.9M
$602.1M
Q1 25
$269.6M
$591.5M
Q4 24
$281.2M
$585.1M
Q3 24
$273.2M
$600.5M
Q2 24
$272.5M
$597.8M
Debt / Equity
BRLT
BRLT
CLB
CLB
Q1 26
Q4 25
0.00×
0.41×
Q3 25
0.00×
0.42×
Q2 25
2.26×
0.48×
Q1 25
3.65×
0.49×
Q4 24
3.63×
0.51×
Q3 24
4.01×
0.56×
Q2 24
4.13×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRLT
BRLT
CLB
CLB
Operating Cash FlowLast quarter
$7.2M
$4.0M
Free Cash FlowOCF − Capex
$5.7M
$517.0K
FCF MarginFCF / Revenue
4.6%
0.4%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$5.8M
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRLT
BRLT
CLB
CLB
Q1 26
$4.0M
Q4 25
$7.2M
$7.9M
Q3 25
$608.0K
$8.5M
Q2 25
$9.1M
$13.9M
Q1 25
$-7.1M
$6.7M
Q4 24
$14.1M
$20.6M
Q3 24
$2.0M
$13.1M
Q2 24
$7.3M
$17.1M
Free Cash Flow
BRLT
BRLT
CLB
CLB
Q1 26
$517.0K
Q4 25
$5.7M
$5.0M
Q3 25
$-3.0K
$6.5M
Q2 25
$7.9M
$10.4M
Q1 25
$-7.9M
$3.9M
Q4 24
$11.9M
$17.4M
Q3 24
$674.0K
$10.4M
Q2 24
$6.5M
$14.3M
FCF Margin
BRLT
BRLT
CLB
CLB
Q1 26
0.4%
Q4 25
4.6%
3.6%
Q3 25
-0.0%
4.8%
Q2 25
7.3%
8.0%
Q1 25
-8.4%
3.1%
Q4 24
10.0%
13.4%
Q3 24
0.7%
7.7%
Q2 24
6.1%
10.9%
Capex Intensity
BRLT
BRLT
CLB
CLB
Q1 26
Q4 25
1.2%
2.1%
Q3 25
0.6%
1.5%
Q2 25
1.1%
2.7%
Q1 25
0.8%
2.3%
Q4 24
1.8%
2.5%
Q3 24
1.3%
2.0%
Q2 24
0.8%
2.2%
Cash Conversion
BRLT
BRLT
CLB
CLB
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
39.36×
2.78×
Q3 24
1.12×
Q2 24
39.51×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRLT
BRLT

US$120.3M97%
Non Us$4.2M3%

CLB
CLB

Segment breakdown not available.

Related Comparisons